Brunswick (NYSE: BC) director receives 697 deferred shares in grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Brunswick Corporation director David C. Everitt reported an acquisition of 697 shares of Brunswick common stock on January 30, 2026, at $80.22 per share. The shares were credited as deferred stock into his director deferred account and will be paid out in set installments after he leaves the board.
Following this transaction, Everitt directly beneficially owned 38,020 Brunswick shares, which include 215 shares acquired through dividend reinvestments in December 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
EVERITT DAVID C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 697 | $80.22 | $56K |
Holdings After Transaction:
Common Stock — 38,020 shares (Direct)
Footnotes (1)
- Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company. Beneficial holdings include 215 shares acquired pursuant to dividend reinvestments in December 2025.
FAQ
What insider transaction did Brunswick (BC) director David C. Everitt report?
Director David C. Everitt reported receiving 697 shares of Brunswick common stock. The shares were credited on January 30, 2026, at $80.22 per share as deferred stock in his director account, increasing his directly beneficially owned holdings.
How do dividend reinvestments affect David C. Everitt’s Brunswick (BC) holdings?
David C. Everitt’s beneficial holdings include 215 Brunswick shares gained through dividend reinvestments. These shares were acquired in December 2025, adding to his overall directly beneficially owned position alongside the newly reported deferred share grant.